===============================================================
                        UNITED STATES 
             SECURITIES AND EXCHANGE COMMISSION
                   Washington, D.C. 20549
                          __________

                           FORM 8-K
                        CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 15, 2004


                    PETMED EXPRESS, INC.
     ----------------------------------------------------
    (Exact name of registrant as specified in its charter) 
 
                Commission file number 000-28827

         FLORIDA                            65-0680967
   ---------------------------              ------------
  (State or other jurisdiction             (IRS Employer
of incorporation or organization)	Identification No.)
	
	
1441 S.W. 29th Avenue, Pompano Beach, Florida       33069
---------------------------------------------     ----------
  (Address of principal executive offices)        (Zip Code)

Registrant's telephone number, including area code: (954) 979-5995
                                                    --------------
                       Not Applicable
 -----------------------------------------------------------
(Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K is intended to 
simultaneously satisfy the filing obligation of the registrant under 
any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under 
    the Exchange Act

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under 
    the Exchange Act





Item 7.01	  Regulation FD Disclosure

     On November 15, 2004, PetMed Express, Inc. issued a press 
release unveiling its new and improved website.  A copy of this news 
release is attached hereto as Exhibit 99.1 and is incorporated herein 
by reference.

     The information furnished in this Item 9, intended to be 
furnished under Item 12, is instead furnished under Item 9 in 
accordance with SEC Release 33-8216.  This information shall not be 
deemed "filed" for purposes of Section 18 of the Securities Exchange 
Act of 1934, as amended (the "Exchange Act") nor shall such 
information be incorporated by reference in any filing under the 
Securities Act of 1933, as amended, or the Exchange Act, except as 
shall be expressly set forth by specific reference in such filing.

Item 9.01   Financial Statements and Exhibits
	
(c)	Exhibits

99.1	Press Release issued by PetMed Express, Inc. on November 15, 2004







                       SIGNATURES


     Pursuant to the requirements of the Securities Exchange Act of 
1934, the Registrant has duly caused this report to be signed on its 
behalf by the undersigned hereunto duly authorized.

					
PETMED EXPRESS, INC.
(The "Registrant")

Date: November 16, 2004

By: /s/  Menderes Akdag
    --------------------------
    Menderes Akdag

    Chief Executive Officer 
    (principal executive officer)

By: /s/  Bruce S. Rosenbloom
    ------------------------------
    Bruce S. Rosenbloom

    Chief Financial Officer
    (principal financial and accounting officer)







                    EXHIBIT INDEX

Exhibit No.				Description


99.1	Press Release issued by PetMed Express on November 15, 2004